Robert M. Califf

Directeur/Membre du Conseil chez Keystone Symposia

Profil

Robert M.
Califf currently works at Keystone Symposia, as Director, Critical Path Institute, as Director from 2021, US Food & Drug Administration, as Commissioner from 2022, National Academy of Medicine (United States), as Member, and Duke University Medical Center, as Vice Chancellor-Clinical & Translational Research from 2013.
Dr. Califf also formerly worked at Clinical Trials Transformation Initiative, as Co-Chairman, Cytokinetics, Inc., as Independent Director from 2018 to 2022, Portola Pharmaceuticals LLC, as Independent Director from 2012 to 2015, Duke Clinical Research Institute, as Founding Director, Proventus, Inc., as Director, Nitrox LLC, as Director, Duke Translational Medicine Institute, as Director, Centessa Pharmaceuticals Plc, as Director from 2021 to 2022, Duke University, as Vice Chancellor-Clinical & Translational Research, US Food & Drug Administration, as Commissioner from 2016 to 2017, National Library of Medicine, as Member-Scientific Counselors, and Alphabet, Inc., as Head-Strategy & Policy.
Dr. Califf received his undergraduate degree and doctorate degree from Duke University School of Medicine.

Postes actifs de Robert M. Califf

Sociétés	Poste	Début
Duke University Medical Center	Corporate Officer/Principal	01/01/1995
National Academy of Medicine (United States)	Corporate Officer/Principal	-
Keystone Symposia	Directeur/Membre du Conseil	-
Critical Path Institute	Directeur/Membre du Conseil	19/05/2021
US Food & Drug Administration	Corporate Officer/Principal	01/02/2022

Anciens postes connus de Robert M. Califf

Sociétés	Poste	Fin
CYTOKINETICS, INCORPORATED	Directeur/Membre du Conseil	16/02/2022
CENTESSA PHARMACEUTICALS PLC	Directeur/Membre du Conseil	16/02/2022
US Food & Drug Administration	Corporate Officer/Principal	01/01/2017
PORTOLA PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	26/01/2015
░░░░ ░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-